Abstract:BackgroundBone morphogenetic protein-2 (BMP2) has been successfully utilized in dentistry to promote new bone formation because of its osteoinductive ability to recruit mesenchymal progenitor cells and induce their differentiation to bone-forming osteoblasts. Recently, novel biphasic calcium phosphate scaffolds have been developed with similar osteoinductive properties capable of forming ectopic bone formation.PurposeThe aim of the present study was to assess whether the combination of BMP2 with this novel Biphasic Calcium Phosphate (BCP) scaffold may additionally promote new bone regeneration.Materials and MethodsCylindrical bone defects measuring 2.5mm were created bilaterally in the femurs of 18 Wistar rats. After 4 weeks, the following six groups were assessed for new bone formation by micro-computed tomography (CT) as well as histological assessment: 1) collagen scaffolds+20g of BMP2; 2) collagen scaffolds+50g of BMP2; 3) collagen scaffolds+100g of BMP2; 4) BCP scaffolds+20g of BMP2; 5) BCP scaffolds+50g of BMP2; and 6) BCP scaffolds+100g of BMP2. Furthermore, tartrate-resistant acid phosphatase (TRAP) staining was utilized to assess osteoclast activity and osteoclast number. The release kinetics of BMP2 from both BCP and collagen scaffolds was investigated over a 14-day period.ResultsThe results from present study demonstrate that BMP2 is able to promote new bone formation in a concentration dependant manner when loaded with either a collagen scaffolds or BCP scaffolds. Micro-CT analysis demonstrated significantly higher levels of new bone formation in groups containing BCP+BMP2 when compared with collagen scaffolds+BMP2. BMP2 had little effect on osteoclast activity; however, less TRAP staining and osteoclast number was observed in the defects receiving collagen scaffolds when compared with BCP scaffolds. The release of BMP2 over time was rapidly released after 1 day on BCP scaffolds whereas a gradually release over time was observed for collagen scaffolds up to 14 days.ConclusionThe osteoinductive properties of BMP2 may further be enhanced by its combination with a novel synthetically fabricated osteoinductive BCP scaffold. Future clinical testing is required to further assess these preliminary findings.

Affinity-selected polysaccharide for rhBMP-2-induced osteogenesis via BMP receptor activation

Studies on Recombinant Human Bone Morphogenetic Protein 2 Loaded Nano-Hydroxyapatite/Silk Fibroin Scaffolds

Enhanced bioactivity of bone morphogenetic protein-2 with low dose of 2-N, 6-O-sulfated chitosan in vitro and in vivo.

The Regulatory Role of Sulfated Polysaccharides in Facilitating Rhbmp-2-induced Osteogenesis

Enhancement of BMP-2-mediated angiogenesis and osteogenesis by 2-N,6-O-sulfated chitosan in bone regeneration

The Immunomodulatory Role of Sulfated Chitosan in BMP-2-mediated Bone Regeneration

Synergistic effect between 2-N,6-O-sulfonated chitosan and bone morphogenetic protein-2

Enhanced Osteogenesis of Bone Morphology Protein-2 in 2-N,6-o-sulfated Chitosan Immobilized PLGA Scaffolds.

Enhancement of bone formation by recombinant human bone morphogenetic protein-2/chitosan bone biomaterials

BMP-2 encapsulated polysaccharide nanoparticle modified biphasic calcium phosphate scaffolds for bone tissue regeneration.

Chitosan/biphasic Calcium Phosphate Scaffolds Functionalized with BMP-2-encapsulated Nanoparticles and RGD for Bone Regeneration.

Localization and Promotion of Recombinant Human Bone Morphogenetic Protein-2 Bioactivity on Extracellular Matrix Mimetic Chondroitin Sulfate-Functionalized Calcium Phosphate Cement Scaffolds.

Enhanced Healing of Rat Calvarial Defects with Sulfated Chitosan-Coated Calcium-Deficient Hydroxyapatite/bone Morphogenetic Protein 2 Scaffolds.

2-N, 6-O sulfated chitosan evokes periosteal stem cells for bone regeneration

Effect of Recombinant Human Bone Morphogenetic Protein Delivered by Chitosan Microspheres on Ectopic Osteogenesis in Rats.

2-N, 6-O-sulfated Chitosan-Assisted BMP-2 Immobilization of PCL Scaffolds for Enhanced Osteoinduction.

Heparin-mediated delivery of bone morphogenetic protein-2 improves spatial localization of bone regeneration

Efficient Delivery of Recombinant Human Bone Morphogenetic Protein (Rhbmp-2) with Dextran Sulfate-Chitosan Microspheres

Tuning the Bioactivity of Bone Morphogenetic Protein-2 with Surface Immobilization Strategies

Addition of a Synthetically Fabricated Osteoinductive Biphasic Calcium Phosphate Bone Graft to BMP2 Improves New Bone Formation

Hollow hydroxyapatite microspheres/chitosan composite as a sustained delivery vehicle for rhBMP-2 in the treatment of bone defects